Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million
Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million
Company Info
Company news
Fri, 01 Nov 2024 07:00:00 GMT
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fri, 01 Mar 2024 08:00:00 GMT
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mon, 31 Oct 2022 07:00:00 GMT
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models | Circulation - AHA Journals
Wed, 08 May 2024 07:00:00 GMT
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results - GlobeNewswire
Fri, 03 Jan 2025 21:05:53 GMT
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Tue, 02 Apr 2024 07:00:00 GMT
Verve Therapeutics Announces Updates on its PCSK9 Program - GlobeNewswire
Sun, 12 Nov 2023 08:00:00 GMT
Verve Therapeutics Announces Interim Data for VERVE-101 - GlobeNewswire
Wed, 20 Jul 2022 07:00:00 GMT
Vertex and Verve Therapeutics Establish Collaboration to - GlobeNewswire
Thu, 15 Jun 2023 07:00:00 GMT
Verve Establishes Global Collaboration with Lilly to - GlobeNewswire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.
Related people
FH